Brazil is the 7th largest healthcare market globally, offering immense potential through its universal public system (SUS) and a rapidly expanding private sector. With a growing demand for advanced medical technology and a clear, albeit rigorous, regulatory framework under ANVISA, the country presents a strategic necessity for global MedTech leaders. Navigating these requirements with expert guidance transforms local barriers into a powerful competitive advantage in Latin America’s most influential economy.